Dianthus Therapeutics | MGTA - Beban Penjualan Dan Administrasi





Beban Penjualan Dan Administrasi Perubahan Tanggal
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 424K 23K 2026-06
Avita Medical AUD 19.54M 516K 2026-06
Celltrion KRW 12.72B 3.4B 2026-06
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 13.56M 1.09M 2026-06
Divis Laboratories Ltd INR 3.4B 10M 2025-06
IQVIA Holdings USD 569M 5M 2026-09
Kangmei Pharma CNY 253.72M 16.66M 2026-06
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Moderna USD 216M 43M 2026-06
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organigram Holdings CAD 26.51M 4.5M 2026-06
Organon & Co USD 407M 27M 2026-09
Ovoca Bio EUR 617K 15K 2025-12
Pharma Mar EUR 15.53M 1.59M 2026-09
Qiagen NV USD 142.33M 60K 2026-06
Revvity USD 275.33M 3.25M 2026-09
Sartorius EUR 216.6M 4.7M 2026-09
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tectonic Therapeutic USD 6.17M 260K 2026-06
Tilray USD 24.85M 1.7M 2025-09
Viatris USD 1.13B 205.7M 2026-06
Xeris Pharmaceuticals USD 61.04M 7.89M 2026-06
Zealand Pharma A/S 104M 12.19M 2026-03
Zz Pientze Pharmaceu CNY 267.85M 44.71M 2026-09